"As a company, CRi is focused on developing advanced imaging solutions that are enabling our customers to breakthrough roadblocks in the development of new therapies, including the promise of translational, personalized and regenerative medicine," states George Abe, CRi's President and CEO. "Our whole team is driven to support the work of scientists and medical professionals such as Dr. Mitalipov."
CRi is a Boston-based biomedical imaging company providing innovative optical imaging solutions to our customers for more than 20 years. Our multidisciplinary team is dedicated to working with our academic and commercial customers to provide high-value solutions. We provide comprehensive imaging and analysis solutions that enable the user to investigate and characterize biological phenotypes while preserving spatial context. With over 80 patents issued and pending, CRi's solution platforms encompass sub-cellular, cellular and whole animal applications. Our innovations are being utilized around the world to enable new breakthroughs in research, health and medicine. For more information visit our website at http://www.cri-inc.com or contact:
David Daniels, Ph.D.
Director of Marketing
CRi
35-B Cabot Road, Woburn, MA 01801 USA
Tel: 1-781-935-9099, extension 149
E-mail: ddaniels@cri-inc.com
| SOURCE Cambridge Research & Instrumentation Copyright©2007 PR Newswire. All rights reserved |